Breast cancer growth signals are enhanced by a protein outside cells

Breast cancer growth signals are enhanced by a protein outside cells
Estrogen receptor α (ERα) positive (red) and the fibronectin-binding protein β1-integrin (green) are found together inside cells in tumors (right) but not in healthy breast tissue (left). Credit: Sampayo et al., 2018

New research uncovers how a sticky protein called fibronectin promotes the activity of estrogen in breast cancer cells. The study, "Fibronectin rescues estrogen receptor α from lysosomal degradation in breast cancer cells," which will be published July 6 in the Journal of Cell Biology (JCB), was led by Rocío Sampayo, a Ph.D. student in Dr. Marina Simian's lab at the Instituto de Nanosistemas, Universidad Nacional de San Martin and Instituto "Ángel H. Roffo," Universidad de Buenos Aires in Argentina. Together they show a novel mechanism of estrogen receptor signaling that is regulated by fibronectin. They found that exposure to fibronectin prolongs the activity of estrogen receptors in breast cancer cells.

The hormone estrogen plays a key role in the development of healthy and, in many cases, cancerous cells. Estrogen attaches to cellular estrogen receptors, which promote cell growth and survival. But too much activity can cause cells to proliferate rapidly, leading to tumor growth. About 75% of breast cancers are considered estrogen receptor positive because estrogen causes those cancers to propagate, Sampayo notes.

As cancerous cells start to invade into surrounding tissue, they encounter the gluey fibronectin protein. "In the normal mammary gland, epithelial cells are not in contact with fibronectin," Sampayo explains. Fibronectin is part of the extracellular matrix, the meshwork of proteins and molecules that surrounds cells. In tumors, the production of this surrounding network often becomes unregulated. Previous research has shown that high levels of fibronectin and its receptor β1-integrin correlate with lower breast survival, but it was not known why.

In the current study, Sampayo and colleagues discovered that fibronectin boosts estrogen receptors' activity in . They found that when breast cancer cells are surrounded by fibronectin, estrogen receptors avoid destruction by lysosomes—cellular garbage disposal units—and can continue to drive cancer cell growth. "This would allow breast cancer cells to become resistant to common endocrine therapy drugs that target the receptor," Sampayo says.

Their research suggests that therapeutics that interfere with fibronectin's influence on the receptor could help treat drug-resistant breast cancers. This work also reveals how the meshwork of proteins surrounding tumors can influence cancer progression.


Explore further

Researchers identify potential therapeutic target in aggressive breast cancer cells

More information: Sampayo et al., 2018. J. Cell Biol. DOI: 10.1083/jcb.201703037
Provided by Rockefeller University Press
Citation: Breast cancer growth signals are enhanced by a protein outside cells (2018, July 6) retrieved 18 February 2019 from https://medicalxpress.com/news/2018-07-breast-cancer-growth-protein-cells.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
24 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more